نتایج جستجو برای: hpv16

تعداد نتایج: 2286  

2016
Li Sun Shubin Xu Lei Liang Liang Zhao Lei Zhang

Cervical carcinoma is a multifactorial malignant tumor and diagnosis is therefore crucial. The aim of the present study was to examine the value of E6 oncoprotein, in human papillomavirus type 16 (HPV16), in the diagnosis of early stage cervical carcinoma and precancerous lesions. Receiver operating characteristic curve was used to analyze accuracy of diagnosis. A total of 124 patients infected...

2014
SONIA ANDERSSON MIRIAM MINTS ULF GYLLENSTEN MONICA LINDELL INGER GUSTAVSSON MATS LAMBE ERIK WILANDER

Human papillomavirus (HPV) 16 is the dominant cofactor in cervical cancer development. The present report investigated the age-specific prevalence of HPV16 in cervical carcinoma in situ (CIS) in females attending organised cervical cancer screening. A retrospective observational study was performed based on individual data from two databases. A total of 162 females aged between 20 and 65 years ...

2016
Junfen Xu Yifeng Fang Xinyu Wang Fenfen Wang Qifang Tian Ying Li Xing Xie Xiaodong Cheng Weiguo Lu

It has been shown that HPV16 E7, but not other genotypes, can bind to scaffold protein CUL2 during inducing cervical carcinogenesis, but the expression level, associated regulating mechanism, and potential carcinogenicity of CUL2 itself is still unknown as yet. Here, we demonstrated that CUL2 was specifically overexpressed in HPV16 positive cervical cancer cells and tissues, and CUL2 expression...

Journal: :Cancer prevention research 2014
Janet L Brandsma Malini Harigopal Nancy B Kiviat Ying Sun Yanhong Deng Daniel Zelterman Paul M Lizardi Veronika S Shabanova Angelique Levi Tian Yaping Xinyuan Hu Qinghua Feng

An accurate biomarker for the follow-up of women positive for human papillomavirus type 16 (HPV16) DNA may improve the efficiency of cervical cancer prevention. Previously, we analyzed all 113 HPV16 CpGs in cervical cytology samples and discovered differential methylation at different stages of premalignancy. In the current study, we identified a methylation biomarker consisting of a panel of 1...

Journal: :The Journal of infectious diseases 2012
Loris Y Hwang Yifei Ma Stephen C Shiboski Sepideh Farhat Janet Jonte Anna-Barbara Moscicki

BACKGROUND Vulnerability of younger women to human papillomavirus 16 (HPV16) infection has been attributed to the predominance of ectocervical columnar epithelia in this age group. However, squamous metaplastic tissue may be more influential. We examined the extent of ectopy and metaplastic activity as risks for HPV16 acquisition in a prospective cohort. METHODS Participants were HPV16 negati...

Journal: :Journal of clinical microbiology 2005
A T Hesselink A J C van den Brule Z M A Groothuismink M Molano J Berkhof C J L M Meijer P J F Snijders

We compared real-time LightCycler and TaqMan assays and the GP5+/6+ PCR/enzyme immunoassay (EIA) to assess the human papillomavirus type 16 (HPV16) load in cervical scrape specimens. Both real-time PCR assays determined the HPV16 load in scrape specimens similarly. The level of agreement between these assays and the GP5+/6+ PCR/EIA was low (P = 0.004), suggesting that the latter method is not s...

Journal: :Journal of immunology 2001
M Evans L K Borysiewicz A S Evans M Rowe M Jones U Gileadi V Cerundolo S Man

Human papillomavirus (HPV) infection, particularly type 16, is causally associated with the development of cervical cancer. The E6 and E7 proteins of HPV are constitutively expressed in cervical carcinoma cells making them attractive targets for CTL-based immunotherapy. However, few studies have addressed whether cervical carcinomas can process and present HPV E6/E7-derived Ags for recognition ...

2015
Chunlin Zhang Zeyi Deng Xiaoli Pan Takayuki Uehara Mikio Suzuki Minqiang Xie Scott M. Langevin

OBJECTIVE To map comprehensively the methylation status of the CpG sites within the HPV16 long control region (LCR) in HPV-positive cancer cells, and to explore further the effects of methylation status of HPV16 LCR on cell bioactivity and E6 and E7 expression. In addition, to analyze the methylation status of the LCR in HPV-positive oropharyngeal squamous cell carcinoma (OPSCC) patients. MET...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2015
Kristina R Dahlstrom Karen S Anderson Julia N Cheng Diego Chowell Guojun Li Marshall Posner Erich M Sturgis

PURPOSE Oropharyngeal carcinoma positive for human papillomavirus type 16 (HPV16) has a significantly better prognosis than oropharyngeal carcinoma unrelated to HPV. Within HPV16-positive oropharyngeal carcinoma, biomarkers of prognosis are urgently needed to individualize care. We hypothesized that serum antibodies specific to HPV16, the major HPV type causing oropharyngeal carcinoma, have bio...

Journal: :Lancet 2007
Jorma Paavonen David Jenkins F Xavier Bosch Paulo Naud Jorge Salmerón Cosette M Wheeler Song-Nan Chow Dan L Apter Henry C Kitchener Xavier Castellsague Newton S de Carvalho S Rachel Skinner Diane M Harper James A Hedrick Unnop Jaisamrarn Genara Am Limson Marc Dionne Wim Quint Bart Spiessens Pascal Peeters Frank Struyf Susan L Wieting Matti O Lehtinen Gary Dubin

BACKGROUND The aim of this interim analysis of a large, international phase III study was to assess the efficacy of an AS04 adjuvanted L1 virus-like-particle prophylactic candidate vaccine against infection with human papillomavirus (HPV) types 16 and 18 in young women. METHODS 18,644 women aged 15-25 years were randomly assigned to receive either HPV16/18 vaccine (n=9319) or hepatitis A vacc...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید